Stocks · News reference

FinVolution Group Affirms FY2026 Sales Guidance of $1.644B-$1.845B

Aug 27, 2026, 10:05 PMBenzinga Newsdesk

FinVolution Group (NYSE:FINV) affirms FY2026 sales outlook from $1.644 billion-$1.845 billion to $1.644 billion-$1.845 billion.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 31, 2026, 2:30 PMAvi Kapoor
Ascendis Pharma, Science Applications International And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones index falling around 400 points on Monday. Shares of Ascendis Pharma A/S (NASDAQ:ASND) rose sharply on Monday. On Sunday, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
AIIR ASND BMM BMRN CHA
BenzingaAug 31, 2026, 9:49 AMBenzinga Insights
FinVolution Gr Q2 2026 Earnings Call: Complete Transcript
On Thursday, FinVolution Gr (NYSE:FINV) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts and
FINV
BenzingaAug 28, 2026, 4:10 PMAvi Kapoor
Gold Falls Over 2%; Elastic Shares Jump After Upbeat Q1 Results
US stocks mixed, Dow up 100 points. Consumer discretionary stocks rise, industrials down. University of Michigan index improves. Elastic, Solstice, and Gap up, while FinVolution, PayPal, and Rubrik down. Oil down 0.5%, gold down 2.2%. European and Asian markets mostly up.
ESTC FINV GAP PYPL RBRK
BenzingaAug 28, 2026, 2:57 PMBenzinga Newsdesk
FinVolution Group shares are trading lower after the company reported a year-over-year decrease in its Q2 adjusted EPS results.
FINV